# FDA recall D-0607-2018

> **Pine Pharmaceuticals, LLC** · Class III · drug recall initiated 2018-03-05.

## Product

Brilliant Blue G for Intraocular Injection 0.5mL vial 0.25 mg/mL  Compounded by: Pine Pharmaceuticals 355 Riverwalk Pkwy Tonawanda, NY 14150. NDC 69194-0358-01

## Reason for recall

Labeling: Label Mix-Up: Brilliant Blue G was labeled with an inaccurate auxiliary label which contained active/inactive ingredient information for incorrect product.

## Distribution

NY only

## Key facts

- **Recall number:** D-0607-2018
- **Recalling firm:** Pine Pharmaceuticals, LLC
- **Classification:** Class III
- **Product type:** drug
- **Status:** Terminated
- **Initiation date:** 2018-03-05
- **Report date:** 2018-03-28
- **Termination date:** 2018-04-23

- **Voluntary/Mandated:** Voluntary: Firm initiated
- **Location:** Tonawanda, NY, United States

## Primary source

FDA Enforcement Reports: https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0607-2018

## Citation

> AI Analytics. FDA recall D-0607-2018. Retrieved 2026-05-28 from https://api.ai-analytics.org/recall/D-0607-2018. Source: US FDA. Licensed CC0.

---

*[Dataset catalog](/datasets/) · [FDA recalls dataset](/datasets/fda-recalls) · CC0 1.0*